MAIA:NYSEMKT, MAIA Biotechnology, Inc.

MAIA stock overview

MAIA Biotechnology, Inc. (MAIA:NYSEMKT) closed at $1.01 on November 16, 2026, up 1.00% on the day. The stock trades 68.3% below its 52-week high of $3.19 and 16.1% above its 52-week low of $0.870. MAIA Biotechnology, Inc. is part of the Health Care sector.

Key figures

Price
$1.01
Day change
+1.00%
Volume
654,620
Average volume
447,692
Market cap
62M+
52-week range
$0.870 – $3.19
50-day average
$1.19
200-day average
$1.39

Price action over the past year

In 252 trading sessions since November 14, 2025, MAIA closed higher on 115 days (46%). Its best day was January 20, 2026 (+26.44%) and its worst was March 3, 2026 (-27.05%). The stock moved 10% or more in a single session 12 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

MAIA news

About MAIA Biotechnology, Inc.

MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

Similar stocks

Find more stocks like MAIA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.